These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6421500)

  • 1. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.
    Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A
    Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
    Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
    Yagi MJ; Zanjani M; Holland JF; Bekesi JG
    Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
    Yagi MJ; Bekesi JG
    Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent.
    Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG
    J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
    Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
    Yagi MJ; Bekesi JG
    Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG
    Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcoma.
    Houghton PJ; Tharp R; Houghton JA; Holland JF; Bekesi JG
    Cancer Chemother Pharmacol; 1988; 22(3):201-4. PubMed ID: 3409455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
    Roboz J; Jiang J; Holland JF; Bekesi JG
    Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT.119.
    Roboz J; Greaves J; Yagi MJ; Holland JF; Bekesi JG
    Pharmacology; 1985; 30(1):52-9. PubMed ID: 3975256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative.
    Allegrucci M; Ballerini P; Romani L; Frati L
    Immunopharmacol Immunotoxicol; 1987; 9(1):71-86. PubMed ID: 3450712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective cytotoxicity of a system L specific amino acid nitrogen mustard.
    Haines DR; Fuller RW; Ahmad S; Vistica DT; Marquez VE
    J Med Chem; 1987 Mar; 30(3):542-7. PubMed ID: 3820226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical activity of 17 beta-[N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-L-alanyl]-5 alpha-dihydrotestosterone (E91) against tumour colony forming units and haematopoietic progenitor cells.
    Rank P; Peter R; Depenbrock H; Eisenbrand G; Schmid P; Pitzl H; Hanauske AR
    Eur J Cancer; 1999 Jun; 35(6):1009-13. PubMed ID: 10533486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
    Catsoulacos P; Politis D; Wampler GL
    Cancer Chemother Pharmacol; 1983; 10(2):129-32. PubMed ID: 6831626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
    Catsoulacos P; Catsoulacos D
    Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
    Pezzoni G; Grandi M; Biasoli G; Capolongo L; Ballinari D; Giuliani FC; Barbieri B; Pastori A; Pesenti E; Mongelli N
    Br J Cancer; 1991 Dec; 64(6):1047-50. PubMed ID: 1764367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).
    Verlicchi F; Boschi S; Visani G; Guidi A; Tosi P; Cavo M; Tura S
    Blut; 1990 Nov; 61(5):311-3. PubMed ID: 2271778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.